Related Experiment Video

Updated: Aug 8, 2026

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

[Hepatocyte growth factor (HGF) in stable and unstable coronary heart disease]

Waldemar Kazberuk1, Krystyna Pawlak, Michał Myśliwiec

  • 1Klinika Nefrologii i Chorób Wewnetrznych AM w Białymstoku. walkaz@poczta.fm

Polskie Archiwum Medycyny Wewnetrznej
|June 2, 2006
PubMed

Insights

Hepatocyte growth factor (HGF) is elevated in patients with unstable angina pectoris (UAP) and stable angina pectoris (SAP) compared to controls. HGF levels correlate with angina symptoms, indicating its role in ischemic heart disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Angiogenesis Research

Context:

  • Ischemic heart diseases are characterized by upregulated angiogenic factors.
  • Hepatocyte growth factor (HGF) is a key angiogenic factor implicated in these conditions.
  • Understanding HGF levels in angina pectoris is crucial for disease assessment.

Purpose:

  • To measure plasma HGF concentrations in patients with stable angina pectoris (SAP) and unstable angina pectoris (UAP).
  • To compare HGF levels between patient groups and a control cohort.
  • To investigate correlations between HGF levels and clinical parameters in SAP patients.

Summary:

  • Plasma HGF levels were significantly elevated in UAP patients versus SAP patients (p<0.01).
  • Both SAP and UAP patient groups exhibited significantly higher HGF levels compared to the control group (p<0.01 and p<0.001, respectively).
  • In SAP patients, HGF levels correlated with heart failure symptoms (p=0.023) and showed a trend with left ventricle ejection fraction and VEGF levels (p=0.08).

Impact:

  • This study demonstrates a significant correlation between elevated HGF plasma levels and the presence of SAP symptoms.
  • Findings suggest HGF may serve as a potential biomarker for assessing disease severity in angina pectoris.
  • The research highlights the role of HGF in the pathophysiology of ischemic heart conditions.

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
TGF - &#946; Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...